The company shared new real-world findings for Aveir DR at the Asia Pacific Heart Rhythm Society (APHRS). These add to strong ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” third-quarter ...

On Wednesday, Abbott Laboratories (NYSE:ABT) reported third-quarter sales of $10.64 billion, up 4.9% year over year, beating the consensus of $10.55 billion. Organic sales growth for the underlying ...

If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing in Abbott Laboratories (NYSE: ABT). Abbott is a longtime leader in the ...

Abbott Labs ABT0.33%increase; green up pointing triangle boosted its earnings in the first quarter and hinted that its full-year guidance might have gotten a lift were it not for looming cost hikes ...

Abbott Laboratories (NYSE:ABT) Q1 2025 Earnings Call Transcript April 16, 2025 Abbott Laboratories beats earnings expectations. Reported EPS is $1.09, expectations were $1.07. Operator: Good morning, ...

The win is Abbott’s third in a row in federal court in Chicago where hundreds of cases over specialized formulas for preterm infants have been consolidated.